LongFNCHApr 2026
Finch Therapeutics
Finch won a significant patent infringement lawsuit, with a potential award of $25 to $80 per share. The company is now pursuing a Chapter 11 filing to eliminate a lease…
FNCH
1 published idea on Finch Therapeutics across 1 fund — 1 long and 0 short.
Each entry below comes from a hedge fund's own investor letter, not a 13F filing, so it carries the reasoning behind the position on Finch Therapeutics: the full thesis, the risks the manager flagged, the conviction level and the time horizon. Positions may have changed since the letter was written.
Finch won a significant patent infringement lawsuit, with a potential award of $25 to $80 per share. The company is now pursuing a Chapter 11 filing to eliminate a lease…